7:30
26th AMLI ANNUAL MEETING 2013
Saturday, August 10, 2013
Continental Breakfast
8:30-8:35
Opening Remarks
Antony Bakke, Ph.D., AMLI President
Plenary Session I
Inflammation in Health and Disease
Chair: Bruce S. Rabin, Ph.D.
8:35
Definition of Inflammation and Measurement of Markers of Inflammation
Bruce S. Rabin, Ph.D., UPMC Presbyterian, Pittsburgh, Pennsylvania
9:15
Glucocorticoid Modulation of Inflammation and Glucocorticoid Resistance
Thaddeus Pace, Ph.D., Emory University School of Medicine, Emory Winship
Cancer Institute, Atlanta, Georgia
10:00
Break
10:30
Modulation of the Inflammatory Response to Enhance Health
Janice Kiecolt-Glaser, Ph.D., Institute for Behavioral Medicine Research, Ohio State University College of Medicine, Columbus, Ohio
11:15
Panel Discussion
11:45
Relaxation CD demonstration
12:00-1:30
Luncheon Seminar hosted by: INOVA Diagnostics, Inc.
Changing Paradigm in the Autoimmune Laboratory Through Chemiluminescence Technology
Michael Mahler, Ph.D., INOVA Diagnostics, Inc.; Thomas Alexander,Ph.D., Summa Health System
Plenary Session 2
Complement
Chairs: Patsy Giclas, Ph.D. and Susie Orton, Ph.D.
2:00
HAE -The Clinical Side of Hereditary Angioedema
Michael M. Frank, M.D., Duke University Medical Center, Durham, North Carolina
2:20
HAE – The Lab Diagnostic Side of Hereditary Angioedema
Ashley Frazer-Abel, Ph.D., National Jewish Health, Denver, Colorado
2:45
Complement Dysregulation in aHUS, DDD and C3GN
Richard J. H. Smith, M.D., Iowa City, Iowa
3:30
Mannose Binding Lectin and Cardiovascular Dysfunction
Gregory L. Stahl, Ph.D., Harvard Medical School, Cambridge, Massachusetts
4:15
Diagnosis of Acquired vs. Inherited Complement Deficiencies
Patricia C. Giclas, Ph.D., National Jewish Health, Denver, Colorado
5:00-7:00
Meet the Exhibitors-Poster Session Reception
Sunday, August 11, 2013
7:30
Continental Breakfast – Committee Meetings – Exhibits Open
Plenary Session 3
Serological Testing for Gastrointestinal Disorders: Past, Present, and Future
Chairs: Evangelos Ntrivalas, M.D., Ph.D. and Ifor Williams, M.D., Ph.D.
8:30
Celiac Disease and the Role of the Clinical Laboratory
Melissa R. Snyder, Ph.D., Mayo Clinic, Rochester, Minnesota
9:30
Promise and Pitfalls of IBD Serologies
Joseph H. Sellin, M.D., Baylor College of Medicine, Houston, Texas
10:30
Break – Exhibits Open
11:00
Immunoassay Methods for the Diagnosis and Management of Food Allergy
Wayne Shreffler, M.D., Massachusetts General Hospital, Boston, Massachusetts
12:00-1:30
Luncheon Seminar hosted by: Thermo Fisher Scientific
Anna Nowak-Węgrzyn, MD, Mount Sinai School of Medicine, New
York, NY
2:00 – 3:00
Erwin Neter Memorial Lecture
What Can the Laboratory Contribute to the Management of the Monoclonal Gammopathies?
Robert Kyle, M.D., Mayo Clinic, Rochester, Minnesota
3:00-3:30
Abstract Award Presentations
3:30-4:00
MLI Business Meeting
4:00-6:00
Meet the Exhibitors – Poster Session Reception
6:00-9:00
Annual Dinner: Savannah Harbor tour, dinner and music/dancing
on the Riverboat Georgia Queen. Boarding and cocktails 6-7 at our hotel’s
dock, tour and dinner 7-9.
Monday, August 12, 2013
7:30
Continental Breakfast – Committee Meetings – Exhibits Open
Plenary Session 4
NK Cells and Interaction with HLA Molecules
Chairs: John Schmitz, Ph.D. and Trivikram Dasu, Ph.D.
8:30
MHC Dependence in NK-mediated Immune Function
Wayne M. Yokoyama, M.D., Washington University School of Medicine, St. Louis, Missouri
9:15
NK Cells and Their Receptors in Cancer and Transplantation
Jeffrey S. Miller, M.D., Masonic Cancer Research Center, Cancer Experimental Therapeutics Initiative, Minneapolis, Minnesota
10:00
Break – Exhibits Open
10:30
Use of NK Cells in Cell-based Therapies
Wing H. Leung, M.D., Ph.D., St. Jude Children’s Research Hospital,
Memphis, Tennessee
11:15
Containing ‘Cytokine-release Syndrome’ during K Cell-mediated Immunotherapy
Subra Malarkannan, Ph.D., Medical College of Wisconsin, Milwaukee, Wisconsin
12:00-1:30
Luncheon Seminar hosted by: Bio-Rad Laboratories Inc.
Update on HIV: New Tests, New Indications, New Algorithms
Bernie Branson, M.D., HIV Laboratory Diagnostics, Centers for Disease Control and Prevention, Atlanta, Georgia
FREE AFTERNOON
Tuesday, August 13, 2013
7:30
Continental Breakfast
Plenary Session 5
New Biologics
Chairs: Vijaya Nagabhushanam Knight, M.D., Ph.D. and Roshini Abraham, Ph.D.
8:30
Clinical Applications and Challenges of B-lymphocyte Monitoring in
Patients with ANCA-associated Vasculitis (AAV) Treated with Rituximab
Tobias Peikert, M.D., Mayo Clinic, Rochester, Minnesota
9:05
Overview of New Biologics, Historical Aspects, Antibody Engineering, Immunogenicity of New Biologics
Juan Carlos Almagro, Ph.D., CTI-Boston, Pfizer, Boston, Massachusetts
9:40
New Paradigms in Immunogenicity Assessment of Biotherapeutics
Vibha Jawa, Ph.D., Amgen, Inc., Woburn, Massachusetts
10:15
Break
10:45
Regulating Immune Responses to Biologics with Tregitopes, A Paradigm-Shifting Solution?
Leslie P. Cousens, Ph.D., EpiVax, Inc., Providence, Rhode Island
11:20
Biologic Immune Response Modifiers: the Good, the Bad, and the Ugly
Mark Ballow, M.D., Women’s and Children’s Hospital, Buffalo, New York
11:55
Closing Remarks